Understanding the obstacles you may face during bioconjugate development, as well as the tools available to help overcome them, can help streamline your product’s path to market.
Article |
By Veera Oruganti and Nikhil Krishnan,Syngene International Ltd.
Explore the typical supply chain challenges faced by global CROs and CDMOs and how one company has transformed its supply chain to mitigate these risks and turn them into a competitive advantage.
White Paper |
By Kimberly B. Shepard, Amanda M. Pluntze, and David T. Vodak,Lonza
Three combination case studies are demonstrated in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.
A biotech with limited experience in the development and manufacture of high potency compounds sought to develop a process for producing a highly potent API used to treat an unmet oncology need.
Learn more about defining the spray-drying process with an emphasis on specific enhancements to accommodate scale-up to commercial-scale equipment of challenging applications or molecules.
Life sciences companies are turning to platform solutions with end-to-end capabilities, along with the underlying infrastructure and ability to implement industry standards. Learn why digital continuity is so important to succeed.
